Dr. Andrew Piper-Vallillo
Claim this profileLahey Hospital and Medical Center
Studies Breast Cancer
Studies Breast cancer
4 reported clinical trials
13 drugs studied
Area of expertise
1Breast Cancer
Stage I
Stage II
ER negative
2Breast Cancer
Stage I
Stage II
ER negative
Affiliated Hospitals
Clinical Trials Andrew Piper-Vallillo is currently running
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting1 award Phase 314 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
More about Andrew Piper-Vallillo
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Andrew Piper-Vallillo has experience with
- Carboplatin
- Pembrolizumab
- Carvedilol
- Biospecimen Collection
- Cyclophosphamide
- Docetaxel
Breakdown of trials Andrew Piper-Vallillo has run
Breast Cancer
Breast cancer
Cancer
Cardiotoxicity
Brain Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Andrew Piper-Vallillo specialize in?
Is Andrew Piper-Vallillo currently recruiting for clinical trials?
Are there any treatments that Andrew Piper-Vallillo has studied deeply?
What is the best way to schedule an appointment with Andrew Piper-Vallillo?
What is the office address of Andrew Piper-Vallillo?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.